TREM2 and Alzheimer disease: The recent discovery that heterozygous coding variants in TREM2 confer an increased risk of Alzheimer's disease (AD) (Guerreiro et al., 2013a, Jin et al., 2014, Jonsson et al., 2013) has reignited interest in understanding the role of this receptor in microglial function.